Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy D. Bridges

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Transplantation|December 1, 2017
Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17Geovani Faddoul, Girish N Nadkarni, Nancy D Bridges, et al.
JAMA|January 19, 2012
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplantsSandy Feng, Udeme D Ekong, Steven J Lobritto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2024
Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trialJames F Markmann, Bryna E Burrell, Jonathan S Bromberg, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Development of a Flexible Multiplex Urine RNA Assay for Detection and Differentiation of Kidney Allograft InjuryKaren S Keslar, Wenjie Xu, Anna A Zmijewska, et al.
Journal of the American Society of Nephrology : JASN|May 1, 2015
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant RecipientsDonald E Hricik, Richard N Formica, Peter Nickerson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18Josef Stehlik, Brian Armstrong, David A Baran, et al.
Science Translational Medicine|November 2, 2022
Selective decrease of donor-reactive T<sub>regs</sub> after liver transplantation limits T<sub>reg</sub> therapy for promoting allograft tolerance in humansQizhi Tang, Joey Leung, Yani Peng, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 6, 2024
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort studyNaoki Tanimine, James F Markmann, Michelle A Wood-Trageser, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2015
Urine Metabolite Profiles Predictive of Human Kidney Allograft StatusKarsten Suhre, Joseph E Schwartz, Vijay K Sharma, et al.
The New England Journal of Medicine|July 5, 2013
Urinary-cell mRNA profile and acute cellular rejection in kidney allograftsManikkam Suthanthiran, Joseph E Schwartz, Ruchuang Ding, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Transplantation|December 1, 2017
Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17Geovani Faddoul, Girish N Nadkarni, Nancy D Bridges, et al.
JAMA|January 19, 2012
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplantsSandy Feng, Udeme D Ekong, Steven J Lobritto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2024
Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trialJames F Markmann, Bryna E Burrell, Jonathan S Bromberg, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Development of a Flexible Multiplex Urine RNA Assay for Detection and Differentiation of Kidney Allograft InjuryKaren S Keslar, Wenjie Xu, Anna A Zmijewska, et al.
Journal of the American Society of Nephrology : JASN|May 1, 2015
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant RecipientsDonald E Hricik, Richard N Formica, Peter Nickerson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18Josef Stehlik, Brian Armstrong, David A Baran, et al.
Science Translational Medicine|November 2, 2022
Selective decrease of donor-reactive T<sub>regs</sub> after liver transplantation limits T<sub>reg</sub> therapy for promoting allograft tolerance in humansQizhi Tang, Joey Leung, Yani Peng, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 6, 2024
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort studyNaoki Tanimine, James F Markmann, Michelle A Wood-Trageser, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2015
Urine Metabolite Profiles Predictive of Human Kidney Allograft StatusKarsten Suhre, Joseph E Schwartz, Vijay K Sharma, et al.
The New England Journal of Medicine|July 5, 2013
Urinary-cell mRNA profile and acute cellular rejection in kidney allograftsManikkam Suthanthiran, Joseph E Schwartz, Ruchuang Ding, et al.
Pageof 4